Yun Yao - 23 Mar 2026 Form 3 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Reporting relationship: 10%+ Owner
Issuer ticker: INDP
Reported as of: 23 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 02 Apr 2026, 19:18:19 UTC
Source filing: View source filing
Reporting owner signature: /s/ Yun Yao

Key filing fact

Yun Yao filed Form 3 for Indaptus Therapeutics, Inc. (INDP) on 02 Apr 2026.

Key facts

This page summarizes Yun Yao's Form 3 filing for Indaptus Therapeutics, Inc. (INDP).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 02 Apr 2026, 19:18.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002120637 Primary reporting owner

Yao Yun

Relationship: 10%+ Owner
Address: C/O INDAPTUS THERAPEUTICS, INC, 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK
Signature: /s/ Yun Yao
Signature date: 02 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INDP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 41,991,000
Date: 23 Mar 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On March 19, 2026, Yun Yao (the "Reporting Person"), the other purchasers and David Elliot Lazar (the "Seller") entered into a securities purchase agreement pursuant to which the Reporting Person acquired 196,800 shares of Series AA Convertible Non-Redeemable Preferred Stock and 253,700 shares of Series AAA Convertible Non-Redeemable Preferred Stock (together, the "Preferred Stock"). Each share of Series AA Preferred Stock is convertible into 20 shares of common stock, and each share of Series AAA Preferred Stock is convertible into 150 shares of common stock. Following the closing on March 23, 2026, the Reporting Person converted all Preferred Stock, resulting in the issuance of 41,991,000 shares of common stock (3,936,000 from Series AA and 38,055,000 from Series AAA).